Desq Long
Sign in

Company

Arcutis Biotherapeutics, Inc.

ARQT · CIK 0001787306

SEC FORM 4
$91,853.31

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 3,674 shares at $25.0009 per share.

Reporting Person Matsuda Masaru · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001628280-26-062732 · filed 2026-09-18 · View filing →

SEC FORM 4
$5,361.33

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 822 shares at $6.5223 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001628280-26-062490 · filed 2026-09-17 · View filing →

SEC FORM 4
$7,652.69

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 1,019 shares at $7.51 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001628280-26-062490 · filed 2026-09-17 · View filing →

SEC FORM 4
$19,460.65

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 2,255 shares at $8.63 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001628280-26-062490 · filed 2026-09-17 · View filing →

SEC FORM 4
$114,371.40

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 4,730 shares at $24.18 per share.

Reporting Person Welgus Howard G. · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001628280-26-062490 · filed 2026-09-17 · View filing →

SEC FORM 4
$249,985.71

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 9,989 shares at $25.0261 per share.

Reporting Person Matsuda Masaru · Officer Title See Remarks · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001628280-26-061444 · filed 2026-09-10 · View filing →

SEC FORM 4
$83,721.48

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 11,148 shares at $7.51 per share.

Reporting Person Curran Terrie · Transaction Code M

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001628280-26-059444 · filed 2026-08-28 · View filing →

SEC FORM 4
$279,027.75

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 11,148 shares at $25.0294 per share.

Reporting Person Curran Terrie · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001628280-26-059444 · filed 2026-08-28 · View filing →

SEC FORM 4
$233,458.76

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 27,052 shares at $8.63 per share.

Reporting Person Curran Terrie · Transaction Code M

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001628280-26-059444 · filed 2026-08-28 · View filing →

SEC FORM 4
$677,095.33

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 27,052 shares at $25.0294 per share.

Reporting Person Curran Terrie · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001628280-26-059444 · filed 2026-08-28 · View filing →

SEC FORM 4
$8,050.72

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 1,072 shares at $7.51 per share.

Reporting Person Curran Terrie · Transaction Code M

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058648 · filed 2026-08-24 · View filing →

SEC FORM 4
$27,912.31

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 1,072 shares at $26.0376 per share.

Reporting Person Curran Terrie · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058648 · filed 2026-08-24 · View filing →

SEC FORM 4
$45,819.00

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 1,697 shares at $27 per share.

Reporting Person Burnett Patrick · Officer Title See Remarks · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 21, 2026

Source: SEC Form 4 · 0001628280-26-058420 · filed 2026-08-21 · View filing →

SEC FORM 4
$5,361.33

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 822 shares at $6.5223 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001628280-26-058008 · filed 2026-08-19 · View filing →

SEC FORM 4
$7,652.69

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 1,019 shares at $7.51 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001628280-26-058008 · filed 2026-08-19 · View filing →

SEC FORM 4
$19,460.65

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 2,255 shares at $8.63 per share.

Reporting Person Welgus Howard G. · Transaction Code M

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001628280-26-058008 · filed 2026-08-19 · View filing →

SEC FORM 4
$123,834.71

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 4,730 shares at $26.1807 per share.

Reporting Person Welgus Howard G. · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001628280-26-058008 · filed 2026-08-19 · View filing →

SEC FORM 4
$24,388.00

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 6,700 shares at $3.64 per share.

Reporting Person Burnett Patrick · Officer Title See Remarks · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056898 · filed 2026-08-13 · View filing →

SEC FORM 4
$174,767.49

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 6,700 shares at $26.0847 per share.

Reporting Person Burnett Patrick · Officer Title See Remarks · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056898 · filed 2026-08-13 · View filing →

SEC FORM 4
$30,212.00

Arcutis Biotherapeutics, Inc. (ARQT)

Acquisition (code M) of 8,300 shares at $3.64 per share.

Reporting Person Burnett Patrick · Officer Title See Remarks · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056898 · filed 2026-08-13 · View filing →

SEC FORM 4
$220,129.28

Arcutis Biotherapeutics, Inc. (ARQT)

Sale of 8,300 shares at $26.5216 per share.

Reporting Person Burnett Patrick · Officer Title See Remarks · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001628280-26-056898 · filed 2026-08-13 · View filing →